Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bifunctional Surfaces With Immobilized Antibodies and Bioactive Peptides Mediate Selective Capture and Proliferation of Endothelial Colony-Forming Cells.

Advanced healthcare materials·2026
Same author

Pure Chitosan Microfluidic Spinning Affords Modular Core-Sheath Fibers and Hand-Crafted Scaffolds with Enhanced Fibroblast Compatibility.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

An Accessible Platform to Quantify Oxygen Diffusion in Cell-Laden Hydrogels and Its Application to Alginate-Immobilized Pancreatic Beta Cells.

Biotechnology and bioengineering·2025
Same author

Internal Delivery and Transport within Cellular Aggregates via Perfusable Glass-Sheathed Hydrogel Microtubes.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

Impact of culture vessel materials on biomanufacturing of dendritic cell-based immunotherapies in closed systems.

Biomaterials science·2025
Same author

Integrating Miniaturized Turbines into Microfluidic Droplet Generating Systems for Scalable Microgel Production.

ACS applied bio materials·2025

Related Experiment Video

Updated: Sep 14, 2025

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

3.3K

Micropocket-Based Differentiation System to Streamline and Scale Stem Cell-Derived Pancreatic Islet Production.

Susan O'Brien1, Chen Li1, Rusvir Trana2

  • 1Department of Chemical Engineering, McGill University, Montreal, QC H3A 0G4, Canada.

ACS Biomaterials Science & Engineering
|July 23, 2025
PubMed
Summary

A novel micropocket hydrogel platform enables controlled aggregate size during stem-cell-derived islet production for type 1 diabetes. This scalable system prevents fusion and oxygen limitations, improving therapeutic potential.

Keywords:
Microwellcontrolled aggregationpancreatic dfferentiationstem cell-derived islets

More Related Videos

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells
06:33

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

2.0K
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

2.9K

Related Experiment Videos

Last Updated: Sep 14, 2025

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

3.3K
Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells
06:33

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

2.0K
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

2.9K

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Stem-cell-derived islets (SC-islets) are a promising alternative to cadaveric islets for type 1 diabetes treatment.
  • Controlling SC-islet aggregate size is crucial for reproducibility and therapeutic efficacy.
  • Current methods face challenges in scalability and maintaining consistent aggregate dimensions due to fusion and oxygen limitations.

Purpose of the Study:

  • To develop and validate a scalable culture system for producing uniform SC-islets.
  • To address the limitations of conventional methods in controlling aggregate size during differentiation.
  • To enhance the potential for therapeutic applications of SC-islets.

Main Methods:

  • Fabrication of a micropocket hydrogel platform with a lip-and-funnel geometry to capture and protect cellular aggregates.
  • Aggregation and differentiation of pancreatic progenitor cells into SC-islets over 23 days within the micropockets.
  • Assessment of aggregate size, shear stress protection, and aggregate retention during media exchange.

Main Results:

  • The micropocket platform maintained consistent SC-islet aggregate sizes (136 μm ± 31 μm SD), comparable to human islets.
  • Aggregates in suspension culture exhibited uncontrolled growth (114 μm ± 8 μm SD to 275 μm ± 62 μm SD) due to fusion.
  • The micropockets reduced shear stress by approximately 50× and prevented aggregate loss during media exchanges, demonstrating scalability.

Conclusions:

  • The micropocket hydrogel system offers a robust and scalable method for producing uniform SC-islets.
  • This approach overcomes key challenges in SC-islet production, including aggregate fusion and microenvironmental control.
  • The technology holds significant potential for the therapeutic manufacturing of stem-cell-derived islets for type 1 diabetes treatment.